Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Selective Estrogen Receptor Modulators × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Advanced Breast Cancer 1

Interventions

pembrolizumab 77 Carboplatin 73 Specimen Handling 58 Cisplatin 58 Magnetic Resonance Spectroscopy 57 Paclitaxel 54 Gemcitabine 45 Docetaxel 38 Dexamethasone 34 Bevacizumab 33 Pemetrexed 31 Radiation 28 durvalumab 27 Oxaliplatin 27 Nivolumab 27 Doxorubicin 27 Cyclophosphamide 27 Fluorouracil 25 atezolizumab 24 Radiotherapy 24 Leucovorin 24 Lenalidomide 23 Capecitabine 21 Letrozole 20 130-nm albumin-bound paclitaxel 20 Rituximab 19 daratumumab 18 Taxes 18 venetoclax 17 Vincristine 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06382948 2026-04-03

ADELA

MedSIR

Phase 3 Recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡